Bill Sponsor
Senate Bill 2920
115th Congress(2017-2018)
Commit to Opioid Medical Prescriber Accountability and Safety for Seniors Act of 2018
Introduced
Introduced
Introduced in Senate on May 22, 2018
Overview
Text
Introduced
May 22, 2018
Latest Action
May 22, 2018
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2920
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Missouri
Republican
Pennsylvania
Democrat
West Virginia
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Commit to Opioid Medical Prescriber Accountability and Safety for Seniors Act of 2018

This bill requires the Centers for Medicare & Medicaid Services (CMS) to identify outlier prescribers of opioids under the Medicare prescription drug benefit and Medicare Advantage prescription drug plans. Specifically, the CMS must: (1) establish an opioid-prescription threshold for determining whether a prescriber is an outlier compared to other prescribers, based on specialty and geographic area; (2) use National Provider Identifiers (unique provider identification numbers currently included on claims for covered drugs) to identify outlier prescribers; and (3) annually notify identified outlier prescribers of their status and provide them with resources on proper prescribing methods. The CMS may also identify and notify outlier prescribers based on co-prescriptions of covered drugs that have adverse effects when used in combination with opioids. Persistent outlier prescribers are subject to additional requirements.

Text (1)
Actions (2)
05/22/2018
Read twice and referred to the Committee on Finance.
05/22/2018
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:42:28 PM